MA56115A - Composés de pyrrolidine - Google Patents
Composés de pyrrolidineInfo
- Publication number
- MA56115A MA56115A MA056115A MA56115A MA56115A MA 56115 A MA56115 A MA 56115A MA 056115 A MA056115 A MA 056115A MA 56115 A MA56115 A MA 56115A MA 56115 A MA56115 A MA 56115A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrrolidine compounds
- pyrrolidine
- compounds
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical class C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382477 | 2019-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56115A true MA56115A (fr) | 2022-04-13 |
Family
ID=66821161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056115A MA56115A (fr) | 2019-06-07 | 2020-06-03 | Composés de pyrrolidine |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11286249B2 (fr) |
| EP (1) | EP3980409A1 (fr) |
| JP (1) | JP6940717B2 (fr) |
| KR (3) | KR102477481B1 (fr) |
| CN (1) | CN114008021A (fr) |
| AU (1) | AU2020287599B2 (fr) |
| BR (1) | BR112021023347A2 (fr) |
| CA (1) | CA3140869A1 (fr) |
| CL (1) | CL2021003202A1 (fr) |
| CO (1) | CO2021016295A2 (fr) |
| CR (1) | CR20210602A (fr) |
| DO (1) | DOP2021000254A (fr) |
| EA (1) | EA202193007A1 (fr) |
| EC (1) | ECSP21088515A (fr) |
| IL (1) | IL288174A (fr) |
| JO (1) | JOP20210319A1 (fr) |
| MA (1) | MA56115A (fr) |
| MX (1) | MX2021014913A (fr) |
| PE (1) | PE20220134A1 (fr) |
| SG (1) | SG11202113244UA (fr) |
| WO (1) | WO2020247429A1 (fr) |
| ZA (1) | ZA202109251B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3235992A1 (fr) | 2021-11-03 | 2023-05-11 | Liang Tan | Derive d'acide phenylpropionique substitue et son utilisation |
| WO2023146785A1 (fr) | 2022-01-26 | 2023-08-03 | Eli Lilly And Company | Composés pyrrolidine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003016265A1 (fr) | 2001-08-17 | 2003-02-27 | Eisai Co., Ltd. | Compose cyclique et agoniste du recepteur ppar |
| WO2005068412A1 (fr) | 2003-12-24 | 2005-07-28 | Esperion Therapeutics, Inc. | Composes a fonction cetone et compositions pour le controle de cholesterol et utilisations associees |
| AU2003300438A1 (en) | 2003-12-24 | 2005-08-03 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
-
2020
- 2020-06-03 MX MX2021014913A patent/MX2021014913A/es unknown
- 2020-06-03 CA CA3140869A patent/CA3140869A1/fr active Pending
- 2020-06-03 KR KR1020217040065A patent/KR102477481B1/ko active IP Right Grant
- 2020-06-03 JO JOP/2021/0319A patent/JOP20210319A1/ar unknown
- 2020-06-03 PE PE2021002037A patent/PE20220134A1/es unknown
- 2020-06-03 JP JP2021505713A patent/JP6940717B2/ja active Active
- 2020-06-03 US US17/056,144 patent/US11286249B2/en active Active
- 2020-06-03 EA EA202193007A patent/EA202193007A1/ru unknown
- 2020-06-03 EP EP20747210.1A patent/EP3980409A1/fr active Pending
- 2020-06-03 KR KR1020227043106A patent/KR102629923B1/ko active IP Right Grant
- 2020-06-03 KR KR1020247002433A patent/KR20240014618A/ko active Application Filing
- 2020-06-03 CN CN202080041924.XA patent/CN114008021A/zh active Pending
- 2020-06-03 MA MA056115A patent/MA56115A/fr unknown
- 2020-06-03 AU AU2020287599A patent/AU2020287599B2/en active Active
- 2020-06-03 SG SG11202113244UA patent/SG11202113244UA/en unknown
- 2020-06-03 WO PCT/US2020/035825 patent/WO2020247429A1/fr active Application Filing
- 2020-06-03 BR BR112021023347A patent/BR112021023347A2/pt unknown
- 2020-06-03 CR CR20210602A patent/CR20210602A/es unknown
-
2021
- 2021-11-16 IL IL288174A patent/IL288174A/en unknown
- 2021-11-18 ZA ZA2021/09251A patent/ZA202109251B/en unknown
- 2021-11-30 CO CONC2021/0016295A patent/CO2021016295A2/es unknown
- 2021-12-01 CL CL2021003202A patent/CL2021003202A1/es unknown
- 2021-12-07 DO DO2021000254A patent/DOP2021000254A/es unknown
- 2021-12-07 EC ECSENADI202188515A patent/ECSP21088515A/es unknown
-
2022
- 2022-02-15 US US17/671,806 patent/US20220169636A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240014618A (ko) | 2024-02-01 |
| KR20230004890A (ko) | 2023-01-06 |
| JP2021524498A (ja) | 2021-09-13 |
| KR20220018494A (ko) | 2022-02-15 |
| BR112021023347A2 (pt) | 2022-04-12 |
| WO2020247429A1 (fr) | 2020-12-10 |
| SG11202113244UA (en) | 2021-12-30 |
| JOP20210319A1 (ar) | 2023-01-30 |
| KR102477481B1 (ko) | 2022-12-15 |
| CA3140869A1 (fr) | 2020-12-10 |
| AU2020287599A1 (en) | 2022-01-06 |
| ZA202109251B (en) | 2024-04-24 |
| DOP2021000254A (es) | 2022-01-16 |
| CO2021016295A2 (es) | 2021-12-10 |
| CR20210602A (es) | 2022-01-06 |
| EA202193007A1 (ru) | 2022-03-25 |
| CL2021003202A1 (es) | 2022-09-09 |
| MX2021014913A (es) | 2022-01-18 |
| IL288174A (en) | 2022-01-01 |
| US20210253559A1 (en) | 2021-08-19 |
| US11286249B2 (en) | 2022-03-29 |
| AU2020287599B2 (en) | 2023-10-19 |
| US20220169636A1 (en) | 2022-06-02 |
| CN114008021A (zh) | 2022-02-01 |
| PE20220134A1 (es) | 2022-01-27 |
| JP6940717B2 (ja) | 2021-09-29 |
| EP3980409A1 (fr) | 2022-04-13 |
| ECSP21088515A (es) | 2022-01-31 |
| KR102629923B1 (ko) | 2024-01-30 |
| JP2021191784A (ja) | 2021-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52560A (fr) | Composés hétéroaryles tétracycliques | |
| MA52948A (fr) | Composés | |
| MA51669A (fr) | Composés | |
| MA53003A (fr) | Composés | |
| MA55564A (fr) | Composés de pyrrole | |
| MA52946A (fr) | Composés | |
| DK3738452T3 (da) | Fordamper | |
| MA56115A (fr) | Composés de pyrrolidine | |
| MA51221A (fr) | Composés de pyrazolopyridinone | |
| DK3715661T3 (da) | Forbedret antihviningsmellemlæg | |
| MA56058A (fr) | Composés tricycliques | |
| IT201900004161A1 (it) | Composti fluoroarilossibenzoeterodiazolici disostituiti | |
| AR122330A1 (es) | Compuestos moduladores de glp-1r | |
| ES1243687Y (es) | Salmorejo | |
| IT201900020430A1 (it) | Espositore | |
| DE202019004111U8 (de) | Weichenstellvorichtung | |
| TH190914S (th) | ขันโตก | |
| TH190910S (th) | ขันโตก | |
| TH190911S (th) | ขันโตก | |
| DK3786413T3 (da) | Rullejalousi | |
| ES1235736Y (es) | Alcoholimetro | |
| ES1234309Y (es) | Bolardo | |
| ES1232841Y (es) | Barbacoa plancha | |
| UA40386S (uk) | Сендвічмейкер | |
| UA40385S (uk) | Сендвічмейкер |